Seshu Tyagarajan
Board Member
Candel Therapeutics, Inc. (CADL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Candel Therapeutics, Inc. (CADL) | Ph.D., RAC Chief Technical and Development Officer | $401,361 | $613,231 |
| 2022 | Candel Therapeutics, Inc. (CADL) | Ph.D., RACChief Technical and DevelopmentOfficer | $235,385 | $916,020 |
| 2021 | Candel Therapeutics, Inc. (CADL) | Ph.D., RACChief Technical and DevelopmentOfficer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.